4.78
  Price0.83%   -0.0400
(After Hours: 4.72 -0.0600 -1.26%)
Aug-11-22 04:30AM Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18thGlobeNewswire Inc.
Aug-09-22 04:23AM Quoin Pharmaceuticals Announces Closing of $16.8 Million Public OfferingGlobeNewswire Inc.
03:24AM Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From YesterdayBenzinga
Aug-08-22 12:49PM Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day SessionBenzinga
06:08AM Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving PremarketBenzinga
Aug-08-22 03:05AM Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From FridayBenzinga
Aug-05-22 03:06AM Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike HigherBenzinga
12:53PM Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day SessionBenzinga
Aug-05-22 12:02PM Dow Drops 150 Points, Crude Oil Rises Over 2%Benzinga
10:08AM Markets Open Lower; U.S. Economy Adds Higher-Than-Expected Jobs In JulyBenzinga
Aug-05-22 09:28AM Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public OfferingGlobeNewswire Inc.
07:35AM Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving PremarketBenzinga
Aug-05-22 06:12AM Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From YesterdayBenzinga
Aug-04-22 01:12AM Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day SessionBenzinga
06:51AM Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving PremarketBenzinga
Aug-04-22 05:54AM This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From YesterdayBenzinga
Jun-06-22 09:47AM Penny Stocks To Buy Now? 4 To Watch With Big NewsPennyStocks
May-06-22 10:02AM Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022Benzinga
Apr-25-22 10:37AM 4 Hot Penny Stocks To Buy For Under $5 Outperforming Dogecoin In AprilPennyStocks
Mar-15-22 08:41AM Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton SyndromeGlobeNewswire Inc.
Mar-10-22 08:00AM Quoin Pharmaceuticals Submits Scientific Advice Briefing Document to EMA for its Lead Asset, QRX003, for Netherton SyndromeGlobeNewswire Inc.
Mar-01-22 08:00AM Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton SyndromeGlobeNewswire Inc.
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a potential therapy for the treatment of Netherton Syndrome; QRX004, a topical lotion for the treatment recessive dystrophic epidermolysis bullosa; and QRX006, a topical lotion to treat rare skin disease. The company was founded in 2018 and is based in Ashburn, Virginia.
Cap:    |  Volume (24h):